3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
16
Neoplasms
15
Prostatic Neoplasms
10
Hematologic Neoplasms
9
Colorectal Neoplasms
8
Lung Neoplasms
6
Hematopoietic and Lymphatic System Neoplasm
5
Squamous Cell Carcinoma of Head and Neck
4
Head and Neck Neoplasms
4
Anatomic Stage I Breast Cancer AJCC v8
4
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Mouth Neoplasms
3
Melanoma
3
Malignant Solid Neoplasm
3
Leukemia, Myeloid, Acute
3
Carcinoma, Non-Small-Cell Lung
3
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Parotid Neoplasms
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Head and Neck Carcinoma
2
Glioma
2
Carcinoma, Squamous Cell
2
Carcinoma, Renal Cell
2
Carcinoma, Basal Cell
2
COVID-19
2
Interventions
Cyclophosphamide
26
fludarabine
18
Dexamethasone
17
pembrolizumab
12
Rituximab
11
Etoposide
10
venetoclax
9
pomalidomide
9
Gemcitabine
9
fludarabine phosphate
7
daratumumab
7
Lenalidomide
7
Bortezomib
7
carfilzomib
6
obinutuzumab
5
glofitamab
5
Vincristine
5
Temozolomide
5
Prednisone
5
Nivolumab
5
Immunotherapy, Adoptive
5
Cisplatin
5
Calcium Dobesilate
5
selinexor
4
cemiplimab
4
Doxorubicin
4
Cytarabine
4
Carboplatin
4
zanubrutinib
3
ruxolitinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Standard of Care
×
90 days
×
Clear all
No trials found.